New Delhi, Nov. 11 -- Danish drugmaker Novo Nordisk on Tuesday announced it was slashing the price of its weight-loss drug Wegovy in India. The company said the monthly price of its once-a-week injection would now be 37% cheaper at Rs.10,850 for the starting dose from Rs.17,345 earlier.

The announcement comes as the Danish drugmaker struggles to grab significant market share in the Indian market before it loses patent exclusivity in March. Once the drug loses patent, several Indian generic drugmakers, including Dr Reddy's, Sun Pharma, Mankind Pharma, Natco, etc are poised to enter the market with lower-priced versions.

Wegovy (semaglutide) was launched in India in June 2025 as a once-a-week pen device in five dose strengths: 0.25 mg, 0....